Avantax Advisory Services’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
22,301
+2,862
| +15% | +$169K | 0.01% | 1003 |
|
|
2025
Q1 | $1.42M | Sell |
19,439
-1,023
| -5% | -$74.9K | 0.01% | 921 |
|
|
2024
Q4 | $1.69M | Buy |
20,462
+2,534
| +14% | +$210K | 0.01% | 793 |
|
|
2024
Q3 | $1.28M | Buy |
17,928
+13
| +0.1% | +$930 | 0.01% | 900 |
|
|
2024
Q2 | $1.23M | Buy |
+17,915
| New | +$1.23M | 0.01% | 876 |
|
|
2023
Q1 | – | Sell |
-3,995
| Closed | -$297K | – | 1505 |
|
|
2022
Q4 | $297K | Buy |
3,995
+195
| +5% | +$14.5K | ﹤0.01% | 1113 |
|
|
2022
Q3 | $226K | Sell |
3,800
-324
| -8% | -$19.3K | ﹤0.01% | 1147 |
|
|
2022
Q2 | $232K | Sell |
4,124
-520
| -11% | -$29.3K | ﹤0.01% | 1135 |
|
|
2022
Q1 | $343K | Buy |
4,644
+45
| +1% | +$3.32K | ﹤0.01% | 944 |
|
|
2021
Q4 | $332K | Buy |
4,599
+148
| +3% | +$10.7K | 0.01% | 930 |
|
|
2021
Q3 | $342K | Sell |
4,451
-105
| -2% | -$8.07K | 0.01% | 866 |
|
|
2021
Q2 | $354K | Buy |
4,556
+177
| +4% | +$13.8K | 0.01% | 837 |
|
|
2021
Q1 | $272K | Buy |
+4,379
| New | +$272K | 0.01% | 848 |
|
|
2020
Q4 | – | Sell |
-4,903
| Closed | -$244K | – | 1098 |
|
|
2020
Q3 | $244K | Buy |
+4,903
| New | +$244K | ﹤0.01% | 1122 |
|